Basilea Pharmaceutica
BSLN.SW
#6322
Rank
NZ$1.05 B
Marketcap
$86.85
Share price
2.38%
Change (1 day)
13.98%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2023: NZ$20.77 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are NZ$0.18 Billion. In 2023 the company made an earning of NZ$20.77 Million a decrease over its 2022 earnings that were of NZ$21.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2023

Annual earnings

Year Earnings Change
2023NZ$20.77 M-5.02%
2022NZ$21.87 M-276.18%
2021-NZ$12.42 Million-55.31%
2020-NZ$27.78 Million-28%
2019-NZ$38.58 Million-27.06%
2018-NZ$52.9 Million62.13%
2017-NZ$32.63 Million-60.94%
2016-NZ$83.52 Million-19.67%
2015-NZ$0.11 Billion48.25%
2014-NZ$70.13 Million12.95%
2013-NZ$62.09 Million-35.16%
2012-NZ$95.76 Million-5.75%
2011-NZ$0.11 Billion-152.57%
2010NZ$0.19 B-199.59%
2009-NZ$0.2 Billion-15.54%
2008-NZ$0.23 Billion22.84%
2007-NZ$0.19 Billion60.07%
2006-NZ$0.12 Billion85.69%
2005-NZ$62.94 Million-43.04%
2004-NZ$0.12 Billion47.04%
2003-NZ$75.14 Million-34.82%
2002-NZ$0.12 Billion